Cyclo Therapeutics’ Trappsol Cyclo was able to induce clinical improvement in seven out of eight children with Neimann-Pick ...

In the space of four days, the number of FDA-approved therapies for ultra-rare genetic disorder Niemann-Pick disease has gone from zero to two, transforming the prospects for patients. IntraBio's ...

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation ...

Cyclo Therapeutics, Inc. ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and ...

Early onset familial Alzheimer disease (eFAD) is hereditary and marked by Alzheimer disease symptoms that appear at an unusually early age. Symptoms can start in a person's thirties, forties, and ...

GAINESVILLE, Fla. - Cyclo Therapeutics, Inc. (NASDAQ:CYTH), a clinical-stage biotechnology firm with a market capitalization of $22.15 million, announced positive data from a sub-study of its pivotal ...

Guggenheim raised the firm’s price target on Zevra Therapeutics (ZVRA) to $21 from $20 and keeps a Buy rating on the shares. The firm, which is ...

Oragenics (NYSE American: OGEN) announced that its Chief Medical Officer, Dr. James P. Kelly, will be a featured panelist at the 12th Annual Brain He ...

Read full article about Anthony Kim joins LIV Golf after 12-year absence from professional game ...

Speaking in the latest edition of bunkered – issue 220, on-sale now from all good newsagents – the tour pro turned commentator articulated his belief that Niemann is overhyped by his Saudi ...

RICHMOND, Va. — Dozens of people have contacted CBS 6 offering to help a 70-year-old woman with a degenerative disc disease who needs assistance picking up a motorized wheelchair. "I was ...